Retracted:  Direct to consumer Internet advertising of statins: an assessment of safety | Zendy

Williams Bethan | Zendy; Brown David | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Retracted: Direct to consumer Internet advertising of statins: an assessment of safety

Author(s) -

Williams Bethan,

Brown David

Publication year - 2012

Publication title -

pharmacoepidemiology and drug safety

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.023

H-Index - 96

eISSN - 1099-1557

pISSN - 1053-8569

DOI - 10.1002/pds.3208

Subject(s) - medicine , pharmacoepidemiology , the internet , advertising , pharmacology , world wide web , computer science , business , medical prescription

The following article from Pharmacoepidemiology and Drug Safety, “Direct to consumer Internet advertising of statins: an assessment of safety”, by Bethan Williams and David Brown, published online on 2nd February 2012 on Wiley Online Library ( wileyonlinelibrary.com ) and in Volume 21, Issue 4, pages 352–365, April 2012, has been retracted by agreement between the authors, the journal Editor‐in‐Chief, and John Wiley & Sons Ltd. The retraction has been agreed due to the inability to verify the accuracy of the data in Appendix 1.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research